| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 09/11/2002 | EP1237874A2 Selective neurokinin antagonists |
| 09/11/2002 | EP1237869A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 09/11/2002 | EP1237868A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 09/11/2002 | EP1237867A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 09/11/2002 | EP1237862A1 Succinate compounds, compositions and methods of use and preparation |
| 09/11/2002 | EP1237852A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect |
| 09/11/2002 | EP0958287B1 Sulfamide-metalloprotease inhibitors |
| 09/11/2002 | EP0837848B1 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 09/11/2002 | EP0736009B1 N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs |
| 09/11/2002 | CN1368958A Arylsulfonamido-substituted hydroxamic acid derivatives |
| 09/11/2002 | CN1368499A Dihydropyridine derivative with structure of guaiacoxypropanol amine and phenoxypropanol amine |
| 09/11/2002 | CN1090614C N-(aroyl) glycine hydroxamic acid derivatives and related compounds |
| 09/10/2002 | US6448406 Improved process for preparation of terfenadine carboxylic acid metabolite and carebastine derivatives; histamine h1 receptor blocking and calcium antagonists; respiratory, allergic, and cardiovascular disease states |
| 09/10/2002 | US6448352 Photoresist monomer, polymer thereof and photoresist composition containing it |
| 09/10/2002 | US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors |
| 09/10/2002 | US6448277 VEGF receptor tyrosine kinase inhibitors |
| 09/10/2002 | US6448276 Such as 1-pyridin-3-yl-4-pyrrolidin-1-yl-but-1-ene; increasing hydration and lubrication of vaginal and cervical tissues; nicotine, epibatidine alkaloids and analogs |
| 09/10/2002 | US6448270 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists |
| 09/10/2002 | US6448269 Such as 6-(n-(4-(aminoiminomethyl)benzoyl)amino)-3,4-dihydro-4,4-dimethyl-2h-1 -benzopyran-2-yl)acetic acid; inhibiting platelet aggregation or fibrinogen binding or preventing thrombosis |
| 09/10/2002 | US6448268 Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
| 09/10/2002 | US6448267 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/10/2002 | US6448263 Synthesis routes for such as 2-amino-n-(2-(3a-(r)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo -(4,3-c) pyridin-5-yl)-1-(r)-benzyloxymethyl-2-oxo-ethyl)-isobutyramide l-tartaric acid salt |
| 09/10/2002 | US6448258 Heterocyclic amine compounds |
| 09/10/2002 | US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 09/10/2002 | US6448243 Serotonin antagonist for treating, ameliorating and preventing spastic paralysis or central muscle relaxants for ameliorating myotonia |
| 09/10/2002 | US6448242 Cyclic amide compounds |
| 09/10/2002 | US6447644 Inhibition of pulp and paper yellowing using nitroxides, hydroxylamines and other coadditives |
| 09/10/2002 | CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase |
| 09/06/2002 | WO2002068416A2 Process of preparing paroxetine and intermediates for use therein |
| 09/06/2002 | WO2002068392A1 N-substituted tetrahydropyridines and their use as pesticides |
| 09/06/2002 | WO2002068391A1 Process for resolving racemic mixtures of piperidine derivatives |
| 09/06/2002 | WO2002068388A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002068387A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002068377A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 09/06/2002 | WO2002067869A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 09/06/2002 | WO2002012534A3 Bio-intermediates for use in the chemical synthesis of polyketides |
| 09/06/2002 | WO2001094612A3 Method for identifying medically valuable active substances |
| 09/06/2002 | CA2439119A1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | CA2438892A1 Process of preparing paroxetine and intermediates for use therein |
| 09/05/2002 | US20020123518 Amide derivative of amlodipine |
| 09/05/2002 | US20020123510 Administering an NR2B subtype selective N-methyl-D-aspartate (NMDA) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke |
| 09/05/2002 | US20020123499 Ligands for dopamine, serotonin or norepinephrine receptors or transporters |
| 09/05/2002 | US20020123498 For inhibiting transport protein; therapy |
| 09/05/2002 | US20020123491 Selective neurokinin antagonists |
| 09/05/2002 | DE10110325A1 Phenylderivate 2 Phenyl derivatives 2 |
| 09/04/2002 | EP1235803A1 Urea compounds having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235802A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235776A1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 09/04/2002 | EP1235575A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 09/04/2002 | EP0906309B1 Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride |
| 09/04/2002 | CN1367777A Benzenamine derivatives as anti-coagulants |
| 09/04/2002 | CN1367678A Method of treating hair loss using ketoamides |
| 09/04/2002 | CN1090187C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090186C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/03/2002 | US6444824 Antiserotonine agents; side effect reduction |
| 09/03/2002 | US6444822 Antidepressants |
| 09/03/2002 | US6444821 Humidity-controlling the crystals of n-(2-(4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-piperidino)ethyl)-1-formyl-4 -piperidinecarboxamide hydrochloride anhydride |
| 09/03/2002 | US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/2002 | US6444686 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 09/03/2002 | US6444685 N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists |
| 09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |
| 09/03/2002 | US6444677 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 09/03/2002 | US6444675 Promoting weight loss and treating eating disorders |
| 09/03/2002 | US6444190 Slurry of a sodium aluminum hydride, lithium or titanium containing additive and a lewis base in solvent; non-pyrophoric; thermal stability |
| 09/03/2002 | CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066429A1 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby |
| 08/29/2002 | WO2002066413A1 Flecainide synthesis |
| 08/29/2002 | WO2002065977A2 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 08/29/2002 | WO2002048109A3 N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization initiators |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002040466A3 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 08/29/2002 | WO2002037937A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002002525A3 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 08/29/2002 | WO2002002520A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2002002506A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2001087288A8 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists |
| 08/29/2002 | WO2001062301A3 Imaging agents for diagnosis of parkinson's disease |
| 08/29/2002 | WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000064443A9 Synergistic effects of amlodipine and atorvastatin |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120154 Method for preparing lactam |
| 08/29/2002 | US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 08/29/2002 | US20020120146 Substituted 3-(piperidin-1-ylmethyl)cyclopentylamines, useful as modulators of the chemokine receptors CCR-5 and/or CC R-3. |
| 08/29/2002 | US20020120042 Of specific high-molecular-weight polyalkylpiperidine derivatives; stabilizing polyolefins against thermal, oxidative or light-induced degradation |
| 08/29/2002 | US20020120007 Benzamide inhibitors of factor Xa |
| 08/29/2002 | US20020119994 LFA-1 Antagonist compounds |
| 08/29/2002 | US20020119980 Antihistamines, antiallergens |
| 08/29/2002 | US20020119979 Cancer therapy |
| 08/29/2002 | US20020119973 Antiinflammatory agents |
| 08/29/2002 | US20020119962 Novel urea compounds, compositions and methods of use and preparation |
| 08/29/2002 | US20020119960 Drug resistance therapy |
| 08/29/2002 | US20020119910 Drug delivery |
| 08/29/2002 | US20020119901 Coating compositions |
| 08/29/2002 | DE19941540C2 Sulfonylcarboxamide zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidämie Sulfonylcarboxamide for the preparation of medicaments for the prophylaxis or treatment of hyperlipidemia |
| 08/29/2002 | CA2439898A1 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 08/29/2002 | CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/28/2002 | EP1233989A2 Inhibition of polymerization of unsaturated monomers |
| 08/28/2002 | EP1233945A1 Heterocyclic ketone and thioester compounds and uses |